Literature DB >> 32655134

The dawning of the digital era in the management of hypertension.

Ryo Matsuoka1, Hiroshi Akazawa2, Satoshi Kodera1, Issei Komuro1.   

Abstract

Awareness, treatment, and control of hypertension are of the utmost importance in conquering stroke and cardiovascular disease. To reduce the global burden of hypertension, the Japanese Society of Hypertension (JSH) established the "JSH Future Plan" based on an increasing need to transform the strategy for combating hypertension. In addition to energizing conventional approaches in basic, translational, and clinical research, the application of rapidly evolving digital health technologies and artificial intelligence to hypertension healthcare and research (digital hypertension) holds promise for providing further insights into the pathophysiology and therapeutic targets and implementing predictive, personalized, and preemptive approaches in clinical practice. With great potential to revolutionize the landscape of hypertension, digital hypertension has some technical, legal, ethical, social, and financial issues to overcome. Given the multidisciplinary framework, digital hypertension requires comprehensive and strategic collaboration among industry, academia, and government to move forward toward the goal of "Future Medicine".

Entities:  

Keywords:  Artificial intelligence; Big data; Information and communication technology; JSH Future Plan; Mobile health

Year:  2020        PMID: 32655134     DOI: 10.1038/s41440-020-0506-1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  47 in total

1.  What has made the population of Japan healthy?

Authors:  Nayu Ikeda; Eiko Saito; Naoki Kondo; Manami Inoue; Shunya Ikeda; Toshihiko Satoh; Koji Wada; Andrew Stickley; Kota Katanoda; Tetsuya Mizoue; Mitsuhiko Noda; Hiroyasu Iso; Yoshihisa Fujino; Tomotaka Sobue; Shoichiro Tsugane; Mohsen Naghavi; Majid Ezzati; Kenji Shibuya
Journal:  Lancet       Date:  2011-08-30       Impact factor: 79.321

Review 2.  Future of Hypertension.

Authors:  Victor J Dzau; Celynne A Balatbat
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

Review 3.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).

Authors:  Satoshi Umemura; Hisatomi Arima; Shuji Arima; Kei Asayama; Yasuaki Dohi; Yoshitaka Hirooka; Takeshi Horio; Satoshi Hoshide; Shunya Ikeda; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Yoshio Iwashima; Hisashi Kai; Kei Kamide; Yoshihiko Kanno; Naoki Kashihara; Yuhei Kawano; Toru Kikuchi; Kazuo Kitamura; Takanari Kitazono; Katsuhiko Kohara; Masataka Kudo; Hiroo Kumagai; Kiyoshi Matsumura; Hideo Matsuura; Katsuyuki Miura; Masashi Mukoyama; Satoko Nakamura; Takayoshi Ohkubo; Yusuke Ohya; Takafumi Okura; Hiromi Rakugi; Shigeyuki Saitoh; Hirotaka Shibata; Tatsuo Shimosawa; Hiromichi Suzuki; Shori Takahashi; Kouichi Tamura; Hirofumi Tomiyama; Takuya Tsuchihashi; Shinichiro Ueda; Yoshinari Uehara; Hidenori Urata; Nobuhito Hirawa
Journal:  Hypertens Res       Date:  2019-09       Impact factor: 3.872

4.  The Japanese Society of Hypertension-Digest of plan for the future.

Authors:  Koichi Node; Takuya Kishi; Atsushi Tanaka; Hiroshi Itoh; Hiromi Rakugi; Yusuke Ohya; Katsuyuki Miura; Tomonori Okamura; Toshihiko Ishimitsu; Atsuhiro Ichihara; Masaaki Ito; Mitsuru Ohishi; Takayoshi Ohkubo; Hisashi Kai; Naoki Kashihara; Kazuomi Kario; Shigeyuki Saitoh; Takuya Tsuchihashi; Satoko Nakamura; Akira Nishiyama; Naoyuki Hasebe; Jitsuo Higaki; Kouichi Tamura; Yuhei Kawano; Takashi Yatabe; Sadayoshi Ito
Journal:  Hypertens Res       Date:  2018-10-11       Impact factor: 3.872

5.  Approval of Stroke and Cardiovascular Disease Control Act in Japan: Comprehensive nationwide approach for prevention, treatment, and patients' support.

Authors:  Hirofumi Nakayama; Kazuo Minematsu; Takenori Yamaguchi; Susumu Miyamoto; Mitsuaki Isobe; Issei Komuro; Yoshio Yazaki
Journal:  Int J Stroke       Date:  2019-09-03       Impact factor: 5.266

6.  Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010.

Authors:  Atsushi Satoh; Hisatomi Arima; Takayoshi Ohkubo; Nobuo Nishi; Nagako Okuda; Ryusuke Ae; Mariko Inoue; Shuji Kurita; Keiko Murakami; Aya Kadota; Akira Fujiyoshi; Kiyomi Sakata; Tomonori Okamura; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  J Hypertens       Date:  2017-02       Impact factor: 4.844

7.  Current Status of Cardiovascular Medicine in the Aging Society of Japan.

Authors:  Satoshi Yasuda; Yoshihiro Miyamoto; Hisao Ogawa
Journal:  Circulation       Date:  2018-09-04       Impact factor: 29.690

Review 8.  Nationwide Actions Against Heart Failure Pandemic in Japan - What Should We Do From Academia?

Authors:  Issei Komuro; Hidehiro Kaneko; Hiroyuki Morita; Mitsuaki Isobe; Hirofumi Nakayama; Kazuo Minematsu; Takenori Yamaguchi; Yoshio Yazaki
Journal:  Circ J       Date:  2019-08-06       Impact factor: 2.993

9.  Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment.

Authors:  Nayu Ikeda; Manami Inoue; Hiroyasu Iso; Shunya Ikeda; Toshihiko Satoh; Mitsuhiko Noda; Tetsuya Mizoue; Hironori Imano; Eiko Saito; Kota Katanoda; Tomotaka Sobue; Shoichiro Tsugane; Mohsen Naghavi; Majid Ezzati; Kenji Shibuya
Journal:  PLoS Med       Date:  2012-01-24       Impact factor: 11.069

10.  Small but Steady Steps in Stroke Medicine in Japan.

Authors:  Kazunori Toyoda; Manabu Inoue; Masatoshi Koga
Journal:  J Am Heart Assoc       Date:  2019-08-08       Impact factor: 5.501

View more
  6 in total

1.  Latest hypertension research to inform clinical practice in Asia.

Authors:  Kazuomi Kario; Masaki Mogi; Satoshi Hoshide
Journal:  Hypertens Res       Date:  2022-04-05       Impact factor: 5.528

2.  The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future.

Authors:  Stefano Omboni; Raj S Padwal; Tourkiah Alessa; Béla Benczúr; Beverly B Green; Ilona Hubbard; Kazuomi Kario; Nadia A Khan; Alexandra Konradi; Alexander G Logan; Yuan Lu; Maurice Mars; Richard J McManus; Sarah Melville; Claas L Neumann; Gianfranco Parati; Nicolas F Renna; Philippe Ryvlin; Hugo Saner; Aletta E Schutte; Jiguang Wang
Journal:  Connect Health       Date:  2022-01-04

3.  Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda.

Authors:  Yogesh Kumar; Apeksha Koul; Ruchi Singla; Muhammad Fazal Ijaz
Journal:  J Ambient Intell Humaniz Comput       Date:  2022-01-13

Review 4.  Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Saulat Siddique; Yuda Turana; Yan Li; Chen-Huan Chen; Jennifer Nailes; Minh Van Huynh; Peera Buranakitjaroen; Hao-Min Cheng; Takeshi Fujiwara; Satoshi Hoshide; Michiaki Nagai; Sungha Park; Jinho Shin; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Narsingh Verma; Tzung-Dau Wang; Yuqing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-02-16       Impact factor: 3.738

Review 5.  The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice.

Authors:  Kazuomi Kario; Noriko Harada; Ayako Okura
Journal:  Hypertens Res       Date:  2022-10-07       Impact factor: 5.528

Review 6.  Novel Digital Technologies for Blood Pressure Monitoring and Hypertension Management.

Authors:  Allison J Hare; Neel Chokshi; Srinath Adusumalli
Journal:  Curr Cardiovasc Risk Rep       Date:  2021-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.